# Mangoceuticals, Inc.: Form 8-K, filed Jul 10, 2025

- Company: [Mangoceuticals, Inc.](/companies/mgrx.md) (CIK 1938046)
- Form: 8-K
- Filed: 2025-07-10
- Accepted by EDGAR: Jul 9, 2025, 21:32 ET
- Period: 2025-07-03
- Accession: 0001641172-25-018467
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1938046/000164117225018467/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1938046/000164117225018467/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1938046/000164117225018467/form8-k.htm

Filed Jul 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-018467. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.
